Momentum Bioscience
Reading, Reading, United Kingdom · Founded 2005
About Momentum Bioscience
Momentum Bioscience Ltd has a novel and innovative approach for the detection of infection in blood and other normally sterile body fluids. There Enzyme Mediated Amplification technology allows universal detection of viable bacteria and fungi in <2 hours vs 1-5 days with current laboratory techniques. It is the only rapid technology available that specifically measures viable organisms Momentum Bioscience Ltd is developing a suite of related technologies collectively termed Enzyme Mediated Amplification (EMA), for the rapid detection of pathogens found in blood and normally sterile fluids (NSF).
Company Facts
- Founded: 2005
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2015)
- Website: momentumbio.co.uk
- Phone: 44 1189 357 344
Industries & Categories
Biotechnology, Health Care, Hospital, Medical Device, Venture Capital
Social Profiles
Canonical: https://fsome.com/organization/momentum-bioscience-2533482 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.